CXT29
CXT29 is an orally active COX-2 inhibitor and a thromboxane A2 receptor (TP) antagonist. CXT29 exhibits COX inhibitory activity and selectivity, with IC50 values of 13 and 722 nM for COX-2 and COX-1 respectively. CXT29 inhibits platelet aggregation induced by U-46619 (HY-108566) (a TP agonist), with an IC50 of 96 nM. CXT29 effectively inhibits the production of TXB₂ and PGE₂, significantly reducing platelet aggregation and inflammatory pain in mice. CXT29 can be used for research on inflammatory pain and cardiovascular diseases.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C22H22FNO3
- Peso molecular:367.41
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
COX-2 13 nM (IC50) |
COX-1 722 nM (IC50) |
TP 96 nM (IC50) |
Chemical Information
-
Peso molecular 367.41
-
Fòrmula C22H22FNO3
-
SMILES
CCC(OCC1)(CC(O)=O)C2=C1C3=CC(F)=CC(CC4=CC=CC=C4)=C3N2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CXT29 Related Classifications
HY-179246 Related Classifications
Powered by Bioz